Antibodies.com, a Cambridge, UK-based digital marketplace that enables life scientists to purchase critical research reagents from primary manufacturers, raised £400k in pre-seed financing.
Nidobirds Ventures joined local angel investors and industry veterans in the funding round.
The company intends to use the funds to expand its catalogue of off-the-shelf reagents, implement new sales and marketing programs to drive customer acquisition, and scale its proprietary AI assisted “Product Matching” tool.
Led by Sebastian Newlove, Antibodies.com is a digital marketplace that enables life scientists to purchase validated antibodies, proteins, and immunoassays directly from the primary manufacturers. The company launched out of beta in May 2018 and has since grown to work with 50+ supply chain partners, offers 70,000+ research reagents, and operates across North America and Europe.
Customers now include some of the world’s largest pharmaceutical companies (including Glaxo Smith Kline, Glenmark Pharmaceuticals, and Merck & Co) and leading academic research institutions (including MIT, Standard University, University of Cambridge, and University of Oxford).